Evidence map›Paper›PMID 28892450›Full record

ArticleAmerican journal of public health2017

2015 Pandemic Influenza Readiness Assessment Among US Public Health Emergency Preparedness Awardees.

Thomas J Fitzgerald, Danielle L Moulia, Samuel B Graitcer, Sara J Vagi, Stephanie A Dopson

Abstract read
In one paragraph

Article in American journal of public health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Thomas J FitzgeraldThomas J. Fitzgerald, Danielle L. Moulia, and Samuel B. Graitcer are with the Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Thomas J. Fitzgerald and Danielle L. Moulia are also with IHRC, Inc, Atlanta. Sara J. Vagi and Stephanie A. Dopson are with the Division of State and Local Readiness, Office of Public Health Preparedness and Response, CDC, Atlanta.
Danielle L MouliaThomas J. Fitzgerald, Danielle L. Moulia, and Samuel B. Graitcer are with the Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Thomas J. Fitzgerald and Danielle L. Moulia are also with IHRC, Inc, Atlanta. Sara J. Vagi and Stephanie A. Dopson are with the Division of State and Local Readiness, Office of Public Health Preparedness and Response, CDC, Atlanta.
Samuel B GraitcerThomas J. Fitzgerald, Danielle L. Moulia, and Samuel B. Graitcer are with the Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Thomas J. Fitzgerald and Danielle L. Moulia are also with IHRC, Inc, Atlanta. Sara J. Vagi and Stephanie A. Dopson are with the Division of State and Local Readiness, Office of Public Health Preparedness and Response, CDC, Atlanta.
Sara J VagiThomas J. Fitzgerald, Danielle L. Moulia, and Samuel B. Graitcer are with the Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Thomas J. Fitzgerald and Danielle L. Moulia are also with IHRC, Inc, Atlanta. Sara J. Vagi and Stephanie A. Dopson are with the Division of State and Local Readiness, Office of Public Health Preparedness and Response, CDC, Atlanta.
Stephanie A DopsonThomas J. Fitzgerald, Danielle L. Moulia, and Samuel B. Graitcer are with the Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Thomas J. Fitzgerald and Danielle L. Moulia are also with IHRC, Inc, Atlanta. Sara J. Vagi and Stephanie A. Dopson are with the Division of State and Local Readiness, Office of Public Health Preparedness and Response, CDC, Atlanta.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo assess how US Public Health Emergency Preparedness (PHEP) awardees plan to respond to an influenza pandemic with vaccination.

methodsThe Centers for Disease Control and Prevention developed the Pandemic Influenza Readiness Assessment, an online survey sent to PHEP directors, to analyze, in part, the readiness of PHEP awardees to vaccinate 80% of the populations of their jurisdictions with 2 doses of pandemic influenza vaccine, separated by 21 days, within 16 weeks of vaccine availability.

resultsThirty-eight of 60 (63.3%) awardees reported being able to vaccinate their populations within 16 weeks; 38 (63.3%) planned to allocate more than 20% of their pandemic vaccine supply to points of dispensing (PODs). Thirty-four of 58 (58.6%) reported staffing as a challenge to vaccinating 80% of their populations; 28 of 60 (46.7%) reported preparedness workforce decreases, and 22 (36.7%) reported immunization workforce decreases between January 2012 and July 2015.

conclusionsAwardees relied on PODs to vaccinate segments of their jurisdictions despite workforce decreases. Planners must ensure readiness for POD sites to vaccinate, but should also leverage complementary sites and providers to augment public health response.

Indexed as

Centers for Disease Control and Prevention, U.S.Civil DefenseDisaster PlanningEmergency Medical ServicesHumansInfluenza, HumanMass VaccinationPandemicsSurveys and QuestionnairesUnited States

Identifiers

PMID28892450
PMCPMC5594392

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.